Christian U. Blank, MD, PhD, Professor of Internal Medicine, staff member at Netherlands Cancer Institute, Professor at the University of Regensburg in Germany, and founding member of the International Neoadjuvant Melanoma Consortium, was the invited discussant of the MD Anderson study of cemiplimab-rwlc in resectable cutaneous squamous cell carcinoma.
2022
Popular ‘Barbie drug’ sparks damning warning
TikTok and the Therapeutic Goods Administration have teamed up to combat the rising popularity of possible melanoma-inducing drug Melanotan, after online videos of people sniffing the illegal substance in order to get a tan skyrocketed in views.
National Skin Cancer Action Week -Walk for Mela-No-More at your own pace.
The Australian Melanoma Research Foundation (AMRF) is urging everyone to Walk for Mela-No-More during National Skin Cancer Action Week (NSCAW) from Monday 21 to Sunday 27 November 2022.
Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence
A new way of reprogramming our immune cells to shrink or kill off cancer cells has been shown to work in the otherwise hard to treat and devastating skin cancer, melanoma.